Literature DB >> 20471016

Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA.

Renata Cífková1, Zdenka Skodová, Jan Bruthans, Vera Adámková, Marie Jozífová, Markéta Galovcová, Peter Wohlfahrt, Alena Krajcoviechová, Rudolf Poledne, Petr Stávek, Vera Lánská.   

Abstract

OBJECTIVE: The aim of our study was to assess longitudinal trends in major CV risk factors in a representative population sample of the Czech Republic.
METHODS: Three cross-sectional surveys of CV risk factors were conducted within the WHO MONICA project in six Czech districts in 1985 (n=2570), 1988 (n=2768), and 1992 (n=2343). In 1997/98, 2000/01, and 2007/08, another three screenings for CV risk factors (a 1% random sample, aged 25-64, mean age 45 years) were conducted in the six original districts (n=1990; 2055; and 2246, respectively).
RESULTS: Over a period of 22/23 years, there was a significant decrease in the prevalence of smoking in males (from 45.0 to 30.5%; p<0.001) and no change in smoking habits in females. BMI increased in males and did not change in females. Both systolic and diastolic blood pressure decreased significantly in both genders, while the prevalence of hypertension declined only in females. Awareness of hypertension also rose as did the proportion of individuals treated by antihypertensive drugs in both genders. Hypertension control improved in either gender. A remarkable drop in total cholesterol was seen in both sexes (males: from 6.21 + or - 1.29 to 5.29 + or - 1.10 mmol/L; p<0.001; females: from 6.18 + or - 1.26 to 5.30 + or - 1.06 mmol/L; p<0.001).
CONCLUSIONS: The striking improvement in CV risk factors documented between 1985 and 2007/8 most likely contributed to the decrease in CV mortality in the Czech Republic. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20471016     DOI: 10.1016/j.atherosclerosis.2010.04.007

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  37 in total

1.  The Gene Score for Predicting Hypertriglyceridemia: New Insights from a Czech Case-Control Study.

Authors:  Jaroslav A Hubacek; Dana Dlouha; Vera Adamkova; Lucie Schwarzova; Vera Lanska; Richard Ceska; Martin Satny; Michal Vrablik
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

Review 2.  Dietary factors associated with hypertension.

Authors:  Dong Zhao; Yue Qi; Zheng Zheng; Ying Wang; Xiu-Ying Zhang; Hong-Juan Li; Hai-Hang Liu; Xiao-Ting Zhang; Jie Du; Jing Liu
Journal:  Nat Rev Cardiol       Date:  2011-07-05       Impact factor: 32.419

3.  The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population.

Authors:  Jaroslav A Hubacek; Ondrej Viklicky; Dana Dlouha; Silvie Bloudickova; Ruzena Kubinova; Anne Peasey; Hynek Pikhart; Vera Adamkova; Irena Brabcova; Eva Pokorna; Martin Bobak
Journal:  Nephrol Dial Transplant       Date:  2011-07-25       Impact factor: 5.992

4.  Desphospho-uncarboxylated matrix Gla protein is associated with increased aortic stiffness in a general population.

Authors:  O Mayer; J Seidlerová; P Wohlfahrt; J Filipovský; J Vaněk; R Cífková; J Windrichová; O Topolčan; M H J Knapen; N E A Drummen; C Vermeer
Journal:  J Hum Hypertens       Date:  2015-05-28       Impact factor: 3.012

5.  Carotid intima-media thickness in young survivors of acute myocardial infarction.

Authors:  Aleš Linhart; Gabriela Dostálová; Jan Bělohlávek; Libor Vítek; Debora Karetová; Michaela Ingrischová; Kristina Bojanovská; Pavel Poláček; Regina Votavová; Renata Cífková
Journal:  Exp Clin Cardiol       Date:  2012

6.  Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population.

Authors:  Otto Mayer; Jitka Seidlerová; Jan Filipovský; Petra Vágovičová; Peter Wohlfahrt; Renata Cífková; Jindra Windrichová; Ondřej Topolčan
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

7.  Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness.

Authors:  Július Gelžinský; Otto Mayer; Jitka Seidlerová; Markéta Mateřánková; Štěpán Mareš; Veronika Kordíková; Ladislav Trefil; Renata Cífková; Jan Filipovský
Journal:  Hypertens Res       Date:  2019-10-21       Impact factor: 3.872

8.  Which serum uric acid levels are associated with increased cardiovascular risk in the general adult population?

Authors:  Alena Krajčoviechová; Peter Wohlfahrt; Jan Bruthans; Pavel Šulc; Věra Lánská; Lenka Eremiášová; Jan Pudil; Aleš Linhart; Jan Filipovský; Otto Mayer; Jiří Widimský; Milan Blaha; Claudio Borghi; Renata Cífková
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-04-09       Impact factor: 3.738

9.  Serum biomarkers, skin autofluorescence and other methods. Which parameter better illustrates the relationship between advanced glycation end products and arterial stiffness in the general population?

Authors:  Július Gelžinský; Otto Mayer; Jitka Seidlerová; Markéta Mateřánková; Štěpán Mareš; Veronika Kordíkova; Ladislav Trefil; Renata Cífková; Jan Filipovský
Journal:  Hypertens Res       Date:  2021-01-12       Impact factor: 3.872

10.  CCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects.

Authors:  J A Hubacek; L Dusek; O Majek; V Adamek; T Cervinkova; D Dlouha; J Pavel; V Adamkova
Journal:  Physiol Res       Date:  2021-03-17       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.